Literature DB >> 7564089

Glomerular hemodynamic responses to pregnancy in rats with severe reduction of renal mass.

A Deng1, C Baylis.   

Abstract

These studies investigate glomerular hemodynamic responses to pregnancy in rats with 5/6th reduction of renal mass of four weeks duration. Both preglomerular and efferent arteriolar resistances (RA and RE) fell significantly at midterm although single nephron glomerular filtration rate (SNGFR) and glomerular plasma flow (QA) were unchanged versus virgins. In late pregnant rats with reduction of renal mass, the gestational fall in RA and RE was maintained and GFR, RPF, SNGFR and QA were higher compared to virgins. The gestational renal vasodilation was prolonged in this model of hypertension versus normals and a peripheral vasodilation is also indicated by the late fall in blood pressure. In virgins with 5/6th reduction of renal mass, PGC is elevated but in pregnant rats PGC fell towards term. The value of Kf was doubled in late pregnancy compared to virgins. All three groups of rats with reduction of renal mass showed similar proteinuria and similar levels of focal glomerular sclerosis, suggesting that pregnancy did not exacerbate the glomerular damage in this model of hypertension and renal disease. A decrease in hematocrit in late pregnancy compared with both virgin and midterm pregnancy indicated a plasma volume expansion. We conclude that when superimposed on hypertension with glomerular damage due to 5/6th reduction of renal mass, pregnancy induced gestational renal and peripheral vasodilation and plasma volume expansion. Since pregnancy was antihypertensive and lowered PGC, there was no hemodynamic basis for pregnancy-associated exacerbation of damage in this model of glomerular injury.

Entities:  

Mesh:

Year:  1995        PMID: 7564089     DOI: 10.1038/ki.1995.264

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  Impact of pregnancy on underlying renal disease.

Authors:  Chris Baylis
Journal:  Adv Ren Replace Ther       Date:  2003-01

Review 2.  Animal models of preeclampsia.

Authors:  Eduardo Podjarny; Gyorgy Losonczy; Chris Baylis
Journal:  Semin Nephrol       Date:  2004-11       Impact factor: 5.299

3.  Pregnant rats treated with a high-fat/prooxidant Western diet with ANG II and TNF-α are resistant to elevations in blood pressure and renal oxidative stress.

Authors:  Mark W Cunningham; Crystal A West; Xuerong Wen; Aihua Deng; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-25       Impact factor: 3.619

Review 4.  Comparison of the surgical resection and infarct 5/6 nephrectomy rat models of chronic kidney disease.

Authors:  Ryan J Adam; Adaysha C Williams; Alison J Kriegel
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-04

Review 5.  Renal physiology of pregnancy.

Authors:  Katharine L Cheung; Richard A Lafayette
Journal:  Adv Chronic Kidney Dis       Date:  2013-05       Impact factor: 3.620

6.  Effects of Shiga toxin type 2 on maternal and fetal status in rats in the early stage of pregnancy.

Authors:  Flavia Sacerdoti; María M Amaral; Elsa Zotta; Ana M Franchi; Cristina Ibarra
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

7.  Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms-like tyrosine kinase 1 pathway.

Authors:  Vincent Dupont; Anders H Berg; Michifumi Yamashita; Chengqun Huang; Ambart E Covarrubias; Shafat Ali; Aleksandr Stotland; Jennifer E Van Eyk; Belinda Jim; Ravi Thadhani; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2022-10-17       Impact factor: 19.456

Review 8.  Of Mice and Men: The Effect of Maternal Protein Restriction on Offspring's Kidney Health. Are Studies on Rodents Applicable to Chronic Kidney Disease Patients? A Narrative Review.

Authors:  Massimo Torreggiani; Antioco Fois; Claudia D'Alessandro; Marco Colucci; Alejandra Oralia Orozco Guillén; Adamasco Cupisti; Giorgina Barbara Piccoli
Journal:  Nutrients       Date:  2020-05-30       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.